Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stryker Repays All Outstanding Debt In Q2, Eyes Ortho/Endoscopic Purchases

This article was originally published in The Gray Sheet

Executive Summary

Stryker is readying for acquisitions in the $100 mil.-$200 mil. range now that the company is "virtually debt-free," CEO John Brown stated in a second-quarter earnings call July 15

You may also be interested in...



Stryker Backs Artificial Disc Developer For Entry Into $1 Bil. Market

A 400-patient, 20-center clinical trial supporting a PMA application for SpineCore's FlexiCore lumbar total artificial disc will conclude enrollment by the first half of 2005, Stryker estimates

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020598

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel